PTX3 predicts severe disease in febrile patients at the emergency department - 07/08/11
, Maarten Limper a, g, Karlien Sierhuis a, Jiri F.P. Wagenaar a, C. Arnold Spek b, Cecilia Garlanda c, Alessia Cotena d, Alberto Mantovani c, d, Hugo ten Cate e, Pieter H. Reitsma f, Eric C.M. van Gorp a
Corresponding author. Center for Experimental and Molecular Medicine, Academic Medical Center, Room G2-132, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. Tel.: +31 20 5667906; fax: +31 20 697 7192.Summary |
Objectives |
The long pentraxin PTX3 is a promising marker of disease severity in severely ill patients. In order to identify patients warranting critical care as quickly as possible, we investigated the value of PTX3 as a biomarker for disease severity in patients presenting with fever at the emergency department.
Methods |
Levels of PTX3 were measured in 211 febrile patients at the emergency and the levels were linked to markers of disease severity including admittance to a special care unit, bloodstream infection and congestive heart failure.
Results |
In comparison to median baseline levels of 2.30ng/ml (interquartile range 1.66–3.67ng/ml), levels of PTX3 were significantly elevated in patients admitted to the intensive-/medium care unit (median value 44.4ng/ml, interquartile range 13.6–105.9ng/ml) and in patients referred to the ward (median value 14.2ng/ml, interquartile range 7.01–25.1ng/ml). In addition, PTX3 was associated with duration of hospital stay and acute congestive heart failure. The levels were predictive for bloodstream infection (AUC=0.71; 95% CI 0.62–0.81).
Conclusions |
PTX3 may be a useful marker for differentiation of patients with severe disease in patients presenting with fever to the emergency department.
Le texte complet de cet article est disponible en PDF.Keywords : Fever, Inflammation, Infection, Pentraxin, Biological marker, Emergency department
Plan
Vol 60 - N° 2
P. 122-127 - février 2010 Retour au numéro
Article précédent
- Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment
- C. van Nieuwkoop, J.W. van't Wout, I.C. Spelt, M. Becker, E.J. Kuijper, J.W. Blom, W.J.J. Assendelft, J.T. van Dissel
- Occurrence of bloodstream infection with different types of central vascular catheter in critically neonates
- Cristiane Silveira de Brito, Denise Von Dolinger de Brito, Vânia Olivetti Steffen Abdallah, Paulo P. Gontijo Filho
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?